↓ Skip to main content

Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia

Overview of attention for article published in Frontiers in Pharmacology, January 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter
5 X users
facebook
1 Facebook page

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
161 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia
Published in
Frontiers in Pharmacology, January 2012
DOI 10.3389/fphar.2012.00101
Pubmed ID
Authors

Adriana Caballero, Kuei Y. Tseng

Abstract

The cannabinoid receptor 1 (CB1R) is the G-protein coupled receptor responsible for the majority of the endocannabinoid signaling in the human brain. It is widely distributed in the limbic system, basal ganglia, and cerebellum, which are areas responsible for cognition, memory, and motor control. Because of this widespread distribution, it is not surprising that drugs that activate CB1R have expected behavioral outcomes consistent with dysregulated signaling from these areas (e.g., memory loss, cognitive deficits, etc). In the context of this review, we present evidence for the role of CB1R signaling in the prefrontal cortex (PFC), an area involved in executive functions, with emphasis on the developmental regulation of CB1R signaling in the acquisition of mature PFC function. We further hypothesize how alterations in CB1R signaling specifically during adolescent maturation might confer liability to psychiatric disorders.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 2%
United Kingdom 3 2%
India 1 <1%
Brazil 1 <1%
Unknown 152 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 29 18%
Student > Bachelor 26 16%
Researcher 19 12%
Student > Master 18 11%
Student > Postgraduate 10 6%
Other 32 20%
Unknown 27 17%
Readers by discipline Count As %
Neuroscience 30 19%
Psychology 30 19%
Medicine and Dentistry 26 16%
Agricultural and Biological Sciences 18 11%
Social Sciences 5 3%
Other 13 8%
Unknown 39 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2022.
All research outputs
#7,783,676
of 25,634,695 outputs
Outputs from Frontiers in Pharmacology
#3,464
of 19,993 outputs
Outputs of similar age
#65,667
of 251,198 outputs
Outputs of similar age from Frontiers in Pharmacology
#38
of 147 outputs
Altmetric has tracked 25,634,695 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 19,993 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,198 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 147 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.